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Absorption of oral cyclosporin and bowel function. R. Wassef, Z.
Cohen, S. Nordgren, and B. Langer. Department of Surgery, Uni-
versity of Toronto, Toronto, Ontario, Canada. The purpose of this
experiment was to study the absorption of oral cyclosporin (CsA). Four
groups of dogs were used. Group I: Five normal dogs were given an
oral dose, 25 mg/kg, of CsA in olive oil. Group 2: Five dogs underwent
total small bowel resection, with anastomosis of the duodenum to the
last 2 cm of ileum. Oral CsA, 25 mg/kg, was administered the following
day. Group 3: Four dogs had total small intestinal autotransplantation.
An oral dose of CsA, 25 mg/kg, was given at 1 and 10 weeks
postoperation. Group 4: Two autotransplanted dogs were administered
olive oil alone, 1 cc/kg, three times a week from week 1 postoperation
for 4 weeks. Oral CsA, 25 mg/kg, was given weekly. Group 1 dogs had
a peak CsA serum level of 1683 + 154 ng/ml. Group 2 dogs had a peak
CsA serum level of only 37 + 36 ng/ml (P < 0.001 compared to group
1). Group 3 dogs had a peak CsA serum level of 678 + 648 ng/ml, or
approximately 40% of the level reached in group 1 (P < 0.05, compared
to group I). After 10 weeks, the peak level remained at 585 + 85 ng/ml.
Group 4: After 2 weeks, the peak CsA serum level was 1355 + 310
ng/ml. After 4 weeks of olive oil administration, the peak CsA serum
level was greater than 2000 ng/ml (P < 0.05, compared to group 3). Our
results suggest that the site of absorption of CsA is a functioning small
bowel. Decreased absorption is noted after autotransplantation and is
postulated to be due to total lymphatic disruption. Regular administra-
tion of olive oil alone appears to enhance absorption of CsA even after
total lymphatic disruption due to total intestinal autotransplantation.
We hypothesize that this enhancement of absorption is due to stimula-
tion of pancreatic enzyme release by repeated doses of olive oil and
may be of importance when utilizing CsA for maximal immunosuppres-
sion in a canine transplantation model.
Hemodynamic effects of hypertonic sodium bicarbonate in cardiac
homotransplanted dogs during rejection. L. Dumont, P. Stanley, and C.
Chartrand. Service de Chirurgie Cardiaque, Hopital Ste-Justine,
Montréal, Quebec, Canada. The hemodynamic changes following an
intravenous bolus of hypertonic sodium bicarbonate (NaHCO3) were
compared in cardiac autotransplanted and homotranspianted dogs to
define the adaptative mechanisms elicited by this pharmacological
stress during acute graft rejection. Nineteen dogs underwent a cardiac
orthotopic homotransplantation and 21 dogs an autotransplantation.
Each animal was equipped with catheters and with an electromagnetic
flow probe positioned around the ascending aorta. Hemodynamic
studies were carried out 3 hr postoperatively and then daily, before and
during bolus administration of NaHCO3 (18.5 mEq of a 1,786
mOsm/liter solution). Base-line hemodynamic data show that cardio-
vascular recovery was complete in all animals 3 to 4 days post-
operatively. Thereafter, the autotransplanted group maintained its
performance while the homotransplanted group showed gradual hemo-
dynamic impairment leading to death by postoperative day 7 to 10.
After NaHCO3, transient hypotension (—20 mm Hg) and myocardial
depression as exemplified by decrement in stroke volume (—20%),
cardiac index (— 20%), stroke power (— 30%), stroke work (—30%),
maximum systolic flow (— 20%), and maximum acceleration (— 18%)
were maximal and similar for both groups in the early postoperative
period. This negative inotropic effect of NaHCO3 gradually diminished
over time in the autotransplanted animals. In contrast, in the
homotransplanted group the hemodynamic impairment elicited by
NaHCO3 remained important and alike until death. These findings
indicate that rejection renders the transplanted heart more sensitive to
the depressive hemodynamic effect of NaHCO3.
Suppression of cytotoxic activity in the Syrian hamster. R. M. O'Hara
Jr., W. R. Duncan, and H. Bitter-Suermann. Laboratory of Trans-
plantation Biology, Daihousie University, Halifax, Nova Scotia. Previ-
ous studies utilizing the Syrian hamster have demonstrated the phe-
notypic absence of cytotoxic T-lymphocyte (CTL) activity in response
to viral or allogeneic stimuli. Whether this was due to the absence of
CTL precursors or suppression of the response was not known. Results
of the present study show CTL activity in hamsters sensitized to
xenoantigen. Conventional in vivo or in vitro sensitization does not
induce CTL activity. However, in vivo sensitization followed by
short-term in vitro culture without additional antigen does allow the
generation of CTL activity. Antigen-specific effector cells can be
demonstrated in response to both mouse and rat stimuli. Prior im-
munization results in the generation of suppressor cells which can
abrogate CTL activity when transferred to naive unirradiated recipi-
ents. Preliminary results indicate that a T-suppressor (Ts) cell is
responsible for the absence of CTL activity. Recently described mono-
clonal antibodies which separate hamster T-cell populations are used to
further characterize the suppressor cell. The specificity and MHC
restriction of the suppressor are also currently under investigation.
Demonstration of suppression of the CTL response to xenoantigens
may explain the lack of anti-viral CTL activity seen in earlier studies.
Prevention of cyclosporin (CyA) induced nephrotoxicity in rats by
16,16-dimethyl prostaglandin E2 (dmPGE2). T. Gilas. Department of
Surgery, University of Toronto, Toronto, Ontario, Canada. Acute and
chronic toxicity directly attributable to CyA administration represents
the most significant problem in the management of transplantation
patients receiving the drug. These studies were designed to determine if
CyA-induced nephrotoxicity could be prevented by dmPGE2 by assess-
ing its effect on animal survival and renal function and histology in a
reproducible model of lethal CyA toxicity in 2- to 4-month-old male
Wistar-Furth strain rats. Oral CyA was administered at 25, 50, and 100
mg/kg/day until all rats within each group died. dmPGE2 was adminis-
tered at a dose of 5 tg/kg subcutaneously at 30 mm before and 1 and 6
hr after each individual CyA dose (total 15 sg/day). Mean survival was
significantly prolonged in each group receiving dmPGE2 as compared to
CyA alone. There were no survivors in the control group after 13 days
of 50 mg/kg/day CyA. However, 7 of 11 (64%) animals receiving
dmPGE2 in addition to CyA for 13 days survived indefinitely (P <
0.001). There was a significant improvement in renal and hepatic
function as assessed by the measurement of creatinine, BUN, bilirubin,
AST and ALP in the dmPGE2-treated animals by day 7 and all
parameters returned to normal by day 21 in the surviving dmPGE2-
treated rats. Kidney specimens obtained after 3, 6, 9, and 12 days of
CyA administration showed a striking improvement in renal morphol-
ogy at all time points for the dmPGE2-treated rats. In a similar
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experiment CyA at a dose of 100 mg/kg/day for 7 days resulted in 13%
(4 of 31) survival of control rats as compared to 87% (27 of 31) for the
dmPGE2-treated animals (P < 0.001) with a similarly marked improve-
ment in renal histology. The renal toxicity was not prevented or
reversed if the animals received the dmPGE2 at the cessation of the
CyA course rather than concomitant with it. The addition of dmPGE2 to
an immunosuppressive CyA protocol did not alter skin allograft sur-
vival.
Pivotal role of the cytotoxic/suppressor T cell subset in rejection of
heart grafts transplanted across isolated class I MHC disparities. R. P.
Lowry, R. D. C. Forbes, J. H. Blackburn, and D. Marghesco. Royal
Victoria Hospital, McGill University, Montreal, Quebec, Canada. We
have explored the requirements for rejection of heart grafts bearing
isolated MHC subregion, RT1A encoded, class I disparities using WF
(RTIA"B"), PVG (RTIACW), and congenic recombinant PVG RTP
(RT1AW) inbred rat strains. As previously reported (PVG x WF)F1
hybrid recipients, incorporating the high responder a haplotype reject
PVG RTU' heart grafts in 11.3 1.2 days (N = 3), in association with
a brisk humoral response and the generation of cytotoxic T cells (Ta).
PVG RT1'1 heart grafts (N = 5)are rejected in 7 to 9 days by sublethally
irradiated (780 rad) (PVG x WF)F1 recipients reconstituted with l0
sensitized syngeneic splenocytes, while grafts survive more than 100
days (N = 4) in unreconstituted recipients. Though hybrid recipients,
reconstituted with 5 x 106 sensitized S1g splenocytes reject PVG
RTI'1 hearts in 10 to 12 days in the absence of specific antibody,
recipients reconstituted with inocula (3 to 4 '< 106) depleted of both
SIg cells as well as Tc and their precursors (OX8) were not rejected
in observation periods exceeding 45 days (N = 8). Significantly (PVG
x WF)F1 do not reject semi-allogeneic (PVG RT1' x WF)F1 heart
grafts in observation periods more than 100 days, despite an equivalent
alloimmune response. This was shown to be related to reduced target
antigen density, indicated by the resistance of (PVG RT11 x WF)F1
targets to lysis by T which lyse PVG RTI" targets. Our results indicate
that the survival of heart grafts bearing isolated class 1 disparities is
determined by target antigen density and demonstrate the critical role of
T in their rejection.
A monoclonal antibody (MA), anti-act I, defines a new late lymphocyte
activation antigen. A. 1. Lazarovits, R. A. Moscicki, D. Camerini, J. T.
Kurnick, A. K. Bhan, L. G. Baird, M. Erikson, A. B. Cosimi, andR. B.
Colvin. Departments of Pathology, Molecular Biology and Surgery,
Massachusetts General Hospital, Boston, Massachusetts, USA. Rest-
ing T lymphocytes exposed to alloantigens (MLC), soluble antigens,
and lectins (PHA) undergo a series of changes termed "activation." A
murine MA (IgG1K) "anti-Act I" that recognizes lymphocytes in the
activated state has been identified in a fusion of NS1 with BALB/c
spleen cells immunized with a human tetanus toxoid (TT) reactive T
lymphoblast line. By immunoperoxidase analysis Act I is restricted to
lymphoid tissue, staining many lymphocytes in the paracortex, germi-
nal centers, and mantle zones. Flow cytometry shows that Act I is
present in increased amounts on activated T and B lymphocytes
compared with normal blood lymphocytes (PBL). Act I expression by
PBL is promoted by PHA, TT, or MLC, and lags behind maximal
thymidine incorporation by about 48 hr. Expression of Act I is induced
on thymocytes by PHAIT cell growth factor stimulation. In vitro,
anti-Act I does not affect T cell proliferation, or T cell-mediated
lymphocytotoxicity. By immunoprecipitation the Act I antigen is a
single band of 63 Kd on SDS gels. The distribution, size, time course,
and functional correlates indicate that Act I is different from Tac, T9,
Tb, 4F2, CBL1, and HLA Class II antigens. Act I has been detected on
the peripheral blood lymphocytes of allograft recipients during rejec-
tion. We hypothesize that Act I is associated with functional activity
and maturation rather than with proliferation. These characteristics
suggest that anti-Act I may be of value in the monitoring and treatment
of these patients.
The effect of cyclosporin on organ blood flow. N. McKenzie, R.
Devineni, W. Vezina, P. Keown, and C. Stiller. With increasing use of
cyclosporin (Cy) significant side effects have become apparent. Acute
side-effects include renal and hepatic dysfunction, convulsions, and
pancreatitis. With chronic Cy administration, we have seen fibrosis
both in the grafted organ and in previously healthy native organs. We
have investigated the possibility that these effects might be related to
alteration in organ perfusion secondary to Cy administration, Organ
blood flow was measured in dogs using microspheres labeled with three
different radionucleides. Control measurements of blood flow were
obtained after injecting Cerium 141 ('41Ce) labeled microspheres. Tem-
porary ischemia of the left kidney was induced by clamping the left
renal artery for 30 mm. The clamp was released and Cy (2.5 mg/kg),
cremophor (Cy vehicle) or an equivalent volume of normal saline given
intravenously over 2 hr. Strontium 85 (85Sr) labeled microspheres were
then injected. Mannitol was next infused in a dose of 0.5 g/kg and a final
microsphere injection of Scandium 46 (46Sc) given 15 mm later, Samples
of both kidneys (cortex and medulla), spleen, pancreas, right and left
lungs, right and left ventricles, frontal, parietal and occipital cerebral
lobes were taken and, following weighing radioactivity measured in a
well scintillation counter. Liver and muscle flow was measured by
Xenon ('33Xr) washout. The results in 15 dogs studied hitherto show (I)
Cy causes significant reduction in both renal (cortex and medulla) and
pancreatic perfusion. (2) A reduction in organ perfusion of similar
magnitude was seen in the other organs studied. (3) Mannitol did not
have a beneficial effect on organ perfusion following Cy. (4) Cremophor
infusion did not significantly alter organ perfusion.
Lymphokine responses induced by cyclosporin in vitro and modified by
corticosteroids. J. M. MacSween, A. D. Cohen, K. Rajaraman, and R.
Rajaraman. Department of Medicine, Dalhousie University, Halifax,
Nova Scotia. We have observed a correlation between lymphokine
responses to concanavalin A and to donor alloantigens and renal
transplant survival in humans. Macrophage migration inhibition factor
(MIF) responses were associated with rejection and migration stimula-
tion with success. MIF responses are suppressed by both cyclosporin
and methylprednisolone (MP) in vitro. Exposure of human lymphocytes
to cyclosporin for 2 hr in the absence of other stimuli resulted in the
subsequent release of migration stimulation factor which was
nondialyzable and which was blocked by the protein synthesis inhibitor
puromycin. Two-hour exposure of normal human lymphocytes to MP in
concentrations from 0.01 to 10 g/ml also resulted in the release of
migration stimulation activity. However, the migration stimulation
produced by 0.1 sg/ml cyclosporin was reduced by the simultaneous
addition of MP at all concentrations tested. MP in the lowest concentra-
tion tested (0.01 tg/ml) reduced migration stimulation responses to
cyclosporin from a mean migration index of 146.7 6.0 to 129.0 4.9
(P < 0.05, paired t test). This may be mediated by soluble factors since
supernatants of the MP-pulsed cells reduced the migration stimulation
activity of supernatants from cyclosporin-pulsed cells in a similar
fashion. These results show that these immunosuppressive drugs stimu-
late the production of lymphokines associated with successful trans-
plantation. However, the two drugs tested were not additive or syner-
gistic with respect to this activity and some inhibition could be
demonstrated by low concentrations of corticosteroid.
Increased monocyte (Mø) size and Fc receptor (FcR) dependent
chemiluminescence (CL) in renal transplant (Tx) patients. D. N. Rush,
D. A. Niven, J. M. Cook, and J. R. Jeffery. Transplant Program,
Health Sciences Centre and University of Manitoba, Winnipeg, Can-
ada. We have shown increased FcR-CL triggered by IgG aggregates (N
= 27) or Ig-treated zymosan (ITZ; N = 17) in Tx MØ relative to the MØ
of controls (C) (N = 18) and (N = 22), respectively (P < 0.01).
Structural and functional properties of human MØ (including FcR
number) have been positively correlated with cell size. Therefore,
mononuclear cells (MNC) of Tx with high FcR-CL (ito 24 mo post-Tx;
N = 16) were reacted with monocyte-specific Mo-2 antibody and
fluoresceinated lgG, and MØ size was determined by FACS analysis. Tx
MØ had an 8-channel shift in mean size relative to C MØ (N = 16) (P <
0.001). In neither population did MØ size correlate with FcR-CL. Tx
and C MØ obtained by adherence (> 85% purity) showed identical PeR
number and avidity by EA-rosetting techniques. The CL response of
neutrophils to C3bR stimulation has been recently shown to be related
to arachidonic acid (AA) metabolism. Therefore, MNC of Tx (N = 10)
and normals (N = 10) were incubated with the phospholipase (PL)
inhibitors mepacrine (10 to 50 jsM) and bromophenacyl bromide (2.5 to
25 M) prior to FcR stimulation with ITZ. We confirmed the depen-
dency of phagocyte CL on AA metabolism, but Tx and normal MØ had
similar inhibitory profiles to the PL inhibitors. In conclusion Tx MØ are
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larger and generate more FcR-CL than normal MØ. However, we have
been unable to correlate the increased FcR-CL of Tx MØ with cell size,
number, or avidity of Fc receptors or an increase in AA metabolism.
The functional significance of these MØ changes is not yet known.
Possible detection of anti-HLA and anti-monocyte antibodies (ab) by a
chemiluminescence (CL) assay. D. N. Rush, J. M. Cook, D. A. Niven,
and J. R. Jeffery. Transplant Program, Health Sciences Centre and
University of Manitoba, Winnipeg, Canada. Monocytes (MØ) could be
useful targets in the pretransplant crossmatch because they express
both HLA and vascular endothelial cell (VEC) antigens. However,
isolation of sufficient numbers of pure, viable monocytes is often
difficult. We therefore attempted to detect anti-HLA and anti-VEC ab
by testing the effects of patient sera on the CL response of unseparated
mononuclear cells (MNC), a reaction that is strictly MØ-dependent.
Patient sera used were (1) sera with reactivity against a lymphocyte
panel and (2) sera reactive only against MØ obtained by adherence from
panel donors. "Reactivity" was defined as a positive 3-hr CDC test.
MNC containing 1 to 2 x iO MØ were incubated with control or test
sera (1 hr) and then with complement (2 hr) at 20°C. The cells were then
stimulated with Ig-treated zymosan and CL was measured in an LKB
1251 luminometer. Inhibition of MNC-CL was seen in 18 of 18 studies
with panel reactive sera, and in one of ten studies with nonreactive sera.
A correlation between the CDC and CL assays was observed in 12 of 14
studies involving nionocyte-reactive (non T-reactive) sera. These pre-
liminary data suggest that it may be possible to detect anti-HLA and
anti-VEC ab by the use of CL assays involving unseparated MNC.
Irradiated spleen allografts—An ideal model for the study of infiltrating
effector cells. W. R. Duncan, S. M. Stepkowski, and H. Bitter-
Suermann. Laboratory of Transplantation Biology, Dalhousie Uni-
versity, Halifax, Nova Scotia. The relative roles of T-delayed type
hypersensitivity and T-cytotoxic cells in organ allograft rejection re-
mains controversial. To gain further insight into the cellular mecha-
nisms of graft rejection, we decided to isolate spleen allograft infiltrating
lymphoid cells to determine if this cell population can transfer the
ability to reject heart allografts. Irradiated (l000R) BN (RTI°) spleen
allografts were transplanted to Lewis (RTV) rats and were quickly
rejected (9 to 12 days). Such allografts were removed prior to being
rejected (5 to9 days), and single cell suspensions of the infiltrating cells
were prepared. T-cells were isolated from this infiltrating population
using rabbit anti-rat IgG Degalan bead columns. Isolated T-cells (8 to 10
x 106) were injected into irradiated (750R) Lewis recipients bearing BN
heart allografts. Lewis rats reconstituted with spleen allograft infil-
trating T-cells rejected BN heart allografts 7 to 13 days after heart
transplantation. Nonreconstituted Lewis recipients rejected BN hearts
within 34 to 37 days. Irradiated (750R) Lewis rats bearing BN hearts
reconstituted with 1.0 x 106 W3/25 0X8- graft infiltrating cells
rejected BN hearts within 7 to 10 days after grafting. Experiments are
in progress to determine whether W3/25 OX8 graft infiltrating cells
can adoptively transfer the ability to reject heart allografts. This model
should prove useful in examining the cellular mechanisms of graft
rejection because it allows for the easy isolation of graft infiltrating cells
without enzymatic treatment and permits the study of the proliferation
and differentiation of lymphoid cells within the graft.
Phenotypic analysis of suppressor cells involved in transplantation
tolerance. S. M. Stepkowski, W. R. Duncan, J. P. Smith, and H.
Bitter-Suermann. Laboratory of Transplantation Biology, Dalhousie
University, Hahfax, Nova Scotia. Suppressor cells of unknown pheno-
type, capable of adaptively transferring clinical transplantation toler-
ance (TT), evolve in AGUS (RTI') or PVG (RTI °) rats that spontane-
ously accept WAG (RTI ) or AGUS spleen allografts, respectively.
Lymph node cells from tolerant hosts (T-LNC) are nonresponsive in the
mixed lymphocyte reaction (MLR), often with equivocal specificity.
T-cells, isolated from tolerant rats utilizing rabbit anti-rat IgG Degalan
bead columns, also were nonresponsive in the MLR. To determine
whether T-suppressor cells (Ts) are responsible for reduced MLR,
co-culture experiments were performed using irradiated unseparated or
purified T-cell populations. T-LNC suppressed the normal MLR (N-
MLR) response to donor stimulators, and in some experiments, third
party responses were suppressed. Purified T-cells and W3/25 - 0X8+
cells specifically suppressed the N-MLR response. However, W3/25
0X8 cells were not suppressive, but instead, specifically enhanced the
N-MLR. These results suggest that OX8 suppressor T-cells may play
a role in the maintenance of spleen allograft-induced TT. Further, our
model of TT, produced in immunologically competent hosts, may
reflect a delicate immunoregulatory balance between alloantigen-
induced immune responsiveness and suppression.
Clinical cardiac transplantation: Preliminary report. A. Guerraty, R.
L. Beaudet, N. Poirier, D. Doyle, R. M. Gagnon, P. Bettez, and P.
Daloze. Notre-Dame Hospital, University of Montreal, Montreal,
Canada. Since July 1982, eight patients received an orthotopic cardiac
graft at our center. Five recipients had terminal idiopathic
cardiomyopathy and three had endstage ischemic cardiac disease. Their
ages ranged from 21 to 47 years. All patients received low dose
prednisone and cyclosponn as immunosuppressive therapy. Three
patients died, one of acute rejection when changed from cyclosporin to
azothioprine, because a cyclosporin-related vasculitis associated to a
PTT-like syndrome was observed. Another patient died 48 hr post-
operatively of cardiogenic shock and a third one died 2 weeks after
transplantation of acute rejection. From the five survivors, three have
not shown any sign of rejection when serial endomyocardial biopsy
specimens were examined for 4, 8, and 20 months of followup,
respectively. One patient had two mild rejection episodes with sponta-
neous resolution, and the other one presented three moderate rejection
episodes necessitating pulse intravenous corticotherapy. Two early
postoperative pulmonary embolisms, transient nephro- and
hepatotoxicity, minor infection as well as benign hypertension were
also observed. All five survivors have normal cardiac performance
when biventricular function was studied by noninvasive methods, and
they are back to normal work 4 to 20 months after surgery. In summary,
(1) cardiac transplantation is an acceptable treatment for selected
patients in endstage cardiac failure, with excellent rehabilitation of the
survivors; (2) cyclosporin reduces rejection episodes, infections, and
high dose steroid-related complications but nephrotoxicity and arterial
hypertension, drug-related, are observed; (3) a case of severe and
generalized vasculitis related to cyclosporin was well studied.
Initial human pancreas transplant and attempts to improve pancreatic
duct anastomosis. I. A. Harle, D. M. Grace, J. V. Frei, D. R. Grant, L.
C. Hutton, P. A. Keown, and C. R. Stiller. Departments of Surgery,
Pathology, Radiology and Medicine, University Hospital and Uni-
versity of Western Ontario, London, Ontario, Canada. We wish to
report our first human pancreas transplant which was complicated by
problems with the pancreatic duct. In an attempt to improve pancreatic
duct anastomosis we carried out a series of experiments in pigs. A
28-year-old juvenile diabetic patient with near normal renal function but
severe retinopathy received a cadaver pancreas transplant April 10,
1983. The duct was left open. Endocrine function was excellent but duct
occlusion with silicone was required 2 weeks later for pancreatic
ascites. The problem recurred and drainage to a Roux-en-Y limb of
jejunum was necessary. Endocrine function was excellent for 4 months
and then stopped abruptly. Immunologic tests indicated probable
rejection despite adequate Cyclosporin A levels. Pancreatic duct
anastomosis was carried out as an autotransplant in ten pigs. Five had
a small opening in the side of the jejunum sutured to the pancreas
around the duct (group A) and five had a direct duct to bowel
anastomosis (group B). Animals were sacrificed after 3 months and the
anastomosis studied by histology and xeroradiographic pancre-
atograms. Group A animals had a superior result due to shorter
operating time, lack of technical problems, reduced periductal fibrosis,
and better patency of the anastomosis. Use of a small jejunal opening
and anastomosis around but not to the pancreatic duct may improve
results of pancreas transplantation in humans.
Liver transplantation—The early experience of a new Canadian pro-
gram. W. J. Wall, J. H. Duff, C. A. Stiller, P. A. Keown, andJ. L. Kutt.
University Hospital, London, Ontario, Canada. A clinical liver trans-
plant program was begun in 1977. Nine adult patients have received
orthotopic liver grafts, six during the past 18 months. The recipients
ranged in age from 16 to 56 years; there were six females and three
males. The diseases for which transplantation was required were
chronic active hepatitis in five patients, primary biliary cirrhosis in two,
secondary biliary cirrhosis in one, and massive liver necrosis in one
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patient. Donors and recipients were ABO compatible but no other effort
was made at tissue matching. Donor livers were preserved by cold flush
perfusion and hypothermic storage. Cold ischemia time ranged from 2
hr 34 mm to 5 hr 10 mm. The first two patients received Imuran and
steroids for immunosuppression and the subsequent recipients all
received Cyclosporin plus steroids. The first three patients in the series
died within 3 months of transplantation from infectious complications.
One patient died from acute irreversible rejection. Five of the six
patients transplanted during the past 18 months are alive at 1, 4, 9, 11,
and 16 months after transplantation. All of the nine recipients had at
least one rejection episode in the first 3 weeks after the transplant. With
one exception, the rejection episodes were easily reversed by a tempo-
rary increase in steroids. Four of the five current survivors have
returned to work. The quality of life of the survivors is excellent.
Renal transplantation (TX) in patients with donor specific T cell
reactivity on noncurrent sera (NCS)—Iongterm followup. C. J. Cardella,
J. A. Falk, P. Halloran, M. Robinette, G. Arbus, and R. Bear.
University of Toronto, Ontario, Canada. The presence of T cell
reactivity to donor cells in noncurrent sera has been considered a
contraindication to renal TX because of the increased risk of either
early or late graft rejection. Our initial study showed that 1-year graft
survival was acceptable but longterm results were unknown. To re-
assess these risks, the results of cadaveric TX in 61 patients followed
for 2 months to 5 years (mean = 22 months) are reported. Four centers
participated in the study. Each patient had a negative crossmatch (XM)
using donor T cells on current sera and a positive XM with NCS taken
I to 88 months (mean 10 months) prior to TX. The testing was
centralized in a single laboratory. The 1-, 2-, 3-, and 4-year actuarial
patient survival is 89, 82, 82, and 82%, respectively. The 1-, 2-, 3-, and
4-year actuarial graft survival is 62, 56, 56, and 56%, respectively.
Fifteen (25%) grafts were lost to rejection. Fourteen (23%) were lost in
the first year post TX and all were in patients who received a secondary
graft; nine (15%) in 3 months or less, and five (8%) greater than 3
months. One graft was lost to rejection at 15 months post TX. Actuarial
graft survival in primary grafts (21 patients) was 76, 68, 68, and 68% at
1, 2, 3, and 4 years, respectively, but was 50, 45, 45, and 45% at 1, 2,
3, and 4 years, respectively in secondary grafts (40 patients). Results of
primary and secondary grafts in patients with a negative XM in all
available sera were similar. This study confirms that renal TX is not
contraindicated in patients with donor specific T cell antibodies in NCS
who are XM negative on current sera. Early and late graft loss to
rejection is not increased. Retransplantation appears to be a risk factor
in both control subjects and in those patients with a positive XM on
NCS.
Cytomegalio virus (CMV) infection in renal transplant (TX) patients.
C. J. Cardella, S. Vas, E. Young, and M. Harding. Toronto Western
Hospital, Toronto, Ontario, Canada. CMV infection is a major cause of
morbidity and mortality in renal TX patients. This study was under-
taken to determine the relationship between post-TX CMV infection
and pre-TX blood transfusion (PBT), CMV status of the recipient at the
time of TX and graft and patient survival. Fifty-seven TX recipients (48
CAD, 9 LRD) were treated with rabbit antithymocyte sera, prednisone,
and azathioprine. CMV titers were performed regularly pre- and
post-TX. Each patient received at least 5 U of blood in the year prior to
TX. Thirty-two percent of those with a negative CMV titer prior to the
5 U became positive after transfusion whereas only 6% of those with a
positive CMV titer pre-transfusion had an increase in titer (P < 0.01).
Twenty-one (36%) patients had a significant rise in CMV titer post-TX.
Eleven (19%) had clinical CMV illness. Four (7%) had severe infection
and one patient died. At the time of TX 15 patients had a negative CMV
titer. Three of these patients had severe post-TX CMV infection as
compared to only one of the patients with a positive CMV titer at the
time of TX (P < 0.01). The 1-year actuarial graft and patient survival in
these patients was 93 and 80%, respectively. The mean number of
rejection episodes (RE) was 1.5 1.3. Forty-two patients had a
positive CMV titer at the time of TX. Sixteen (38%) had a significant
increase in CMV titer post-TX. The 1-year actuarial patient and graft
survival in these patients was 88 and 76%, respectively. The mean
number of RE was 1.2 1.1. PBT appears to induce a positive CMV
titer in a significant number of patients who had a negative titer prior to
the transfusions. Severe post-TX CMV infection occurred more often in
patients who had a negative CMV titer at the time of TX. Graft and
patient survival and RE were similar in recipients with a positive or
negative CMV titer at the time of TX.
Sequential Minnesota antilymphoblast globulin (MALG) and (CY)
therapy after cadaver renal transplantation. D. Ludwin, N. White, S.
Tsai, and F. K. M. Smith. Division of Nephrology, McMaster Uni-
versity, Hamilton, Ontario, Canada. Between March 1981 and Febru-
ary 1984, 40 cadaver renal allograft recipients were treated initially with
prophylactic MALG, prednisone, and later azathioprine, Eight were
converted to CY, 48.2 10.2 (saM) days post-transplant and are the
subject of this report. Seven patients were switched because of rejec-
tion, either uncontrolled by MALG and/or steroids or because of drug
side effects. One was electively switched as part of a pilot study of
sequential therapy. CY was never administered together with MALG or
azathioprine. Trough CY levels were rarely greater than 350 nglliter,
except for one patient (who had no infectious complications). Antirejec-
tion therapy consisted of three to five boluses of 200 to 250 mg of
methylprednisolone (maximum three courses) with or without a second
course of MALG. Three rejection episodes occurred in two patients
post switching. Mean followup time was 6.7 1.3 (range, 1.5 to 11)
months post-transplant. The patient switched electively died of fatal
EBV-associated lymphoproliferative disorder, complicated by pneu-
mocystis pneumonia and strep viridans septicemia. One other graft was
lost at 11 months due to chronic rejection. The mean 1 month post-
transplant creatinine was 248 63 moles/liter with current creatinine
275 25 j.tmoles/liter. Other complications were: combined CMV and
pneunlocystis pneumonia (one patient); CMV (one patient) and
pneumocystis (one patient) pneumonias; acute ureteric disruption (one
patient) and chronic ureteric obstruction (one patient); obstructive
lymphocele (one patient); duodenal ulcer (one patient) and cataracts
(one patient). We conclude: (1) CY can be effectively used to salvage
cadaver kidneys with an acceptable short term mortality, and (2)
elective switching must be done with caution in view of the high
morbidity.
Complications related to the route of Minnesota antilymphoblast glob-
ulin (MALG) administration in renal transplant recipients. D. Ludwin,
N. White, S. Tsai, W. Orovan, and E. K. M. Smith. Divisions of
Nephrology and Urology, McMaster University, Hamilton, Ontario,
Canada. Forty-three recipients of renal transplants (including one living
related kidney) received MALG between March 1981 and February
1984. MALG was used prophylactically for about 21 days and/or
therapeutically for rejection (generally for 14 days). Because of its
propensity to sclerose vessels, MALO was administered using either an
existing fistula (15 patients) or a subclavian catheter (SC) inserted either
immediately postoperatively or for rejection therapy (32 patients). In
some patients, both fistulae and SC were used (4 patients). The fistula
was used for 20 courses of MALG resulting in fistula loss in five (25%).
In most cases, thrombosis was associated with a clinically severe
inflammatory reaction. Thirty-two patients had 40 SC inserted. SC were
removed after 25.3 2.6 (sEM) days. No mortality was attributable to
SC and there were no episodes of pneumothorax in the series. One
patient had mediastinal bleeding requiring transfusion only and one
patient had recurrent arrhythmias associated with the infusion of
heparin. Local infection necessitated the removal of 14 SC (35%), eight
patients also receiving antibiotic therapy. Staphylococcus species were
most commonly isolated, but one patient (a diabetic) grew Klebsiella
and required tobramycin. No episodes of systemic infection complicat-
ing SC were noted. We conclude: (1) MALG causes an unacceptably
high incidence of fistula loss and (2) the use of SC in immunosuppressed
renal transplant recipients is associated with an acceptable morbidity.
Switches from cyclosporin to imuran in renal graft recipients: An
analysis of clinical laboratory, needle biopsy, and fine needle aspiration
data. A. S. MacDonald, P. Belitsky, H. Bitter-Suermann, R. Campbell,
A. Cohen, and S. Lannon. Transplant Service, Victoria General
Hospital, Halifax, Nova Scotia. Of 135 renal graft recipients in our
institution treated with cyclosporin 15 have been switched to imuran,
one living related and 14 cadaver recipients. The switches were made
from 18 days to 134 weeks post-transplant. All patients had pre- and
post-switch needle biopsies or fine needle aspirations (FNA) or both.
Six patients were switched because of uncontrolled or chronic rejec-
Abstracts 597
tion, all within the first 6 months. One patient switched at 18 days
improved and has normal renal function at 16 months. The other five all
deteriorated, two quickly losing their grafts. Five patients were
switched because of CyA toxicity between 18 and 104 weeks. All
patients improved although one later developed rejection and was
restarted on CyA. In four patients the diagnosis of mixed toxicity and
rejection was based on clinical and morphological grounds. Only one of
these patients deteriorated early although two had late onset rejections.
Except where chronic humoral (vascular) rejection was the major
problem FNA was a much better predictor than biopsy of the sub-
sequent response to the therapeutic change. A pattern of creatinine
responses to changes in serum CyA trough levels has emerged which is
helpful in distinguishing toxicity from rejection.
Aseptic necrosis following renal transplantation—A 25-year experi-
ence. D. Farge, P. S. Parfrey, C. St. André, Y. L. Kuo, and R. D.
Guttmann. Royal Victoria Hospital, McGill University, Montreal,
Canada. To assess the incidence and risk factors associated with
aseptic necrosis, we studied 221 patients whose renal transplants
functioned for more than 1 year. Serial bone x-rays were performed in
208 recipients (94%). Total prednisone dose I and 4 months after
transplantation and cumulative dose at the development of aseptic
necrosis or last followup were recorded, as were transplant and liver
function, presence of hyperparathyroidism 1 year after transplant, and
duration of dialysis before transplantation. The incidence of aseptic
necrosis before 1971 was 30% (17 of 57 patients). In 1971 new steroid
protocols were introduced and the subsequent incidence of aseptic
necrosis was 4% (6 of 151 patients). Aseptic necrosis was first diag-
nosed 17.3 3.1 months after transplantation. In these patients the
total dose of steroids given in the first month was 2.14 0.37 g, in the
first 4 months 6.59 0.62 g and prior to development of aseptic
necrosis 14.84 2.02 g. In the group who did not develop aseptic
necrosis steroid doses were higher than in those who did: 4.18 0.94
g at 1 month, 7.93 0.27 g at 4 months and 35.77 1.58 g at last
followup (mean followup = 66.8 3.2 months). Duration of dialysis
before transplantation was 19.7 5.5 months in aseptic necrosis group
and 15.0 1.2 months in the remainder. No relationship between
transplant function, liver dysfunction or presence of hyperpara-
thyroidism and the occurrence of aseptic necrosis was observed.
During the last decade the incidence of aseptic necrosis following renal
transplantation has dropped dramatically, for reasons that are still
unclear.
Cyclosporin (CyA)-induced lymphoproliferation despite controlled
CyA blood levels in a renal allograft recipient. J. B. Dossetor, T.
Kovithavongs, M. Salkie, and J. Preiksaitis. Departments of Medicine
and Laboratory Medicine, University of Alberta, Edmonton, Alberta,
Canada. A male, aged 55, in renal failure because of chronic glomerulo-
nephritis received a HLA-identical renal allograft from his sister in May
1983. Postoperatively, he received cyclosporin, prednisone (20
mg/alt.die.) and sulfinpyrazone (Anturan 100 mg, 4 x /day). Unexpect-
edly high doses of CyA were needed to control blood CyA levels of 50
to 200 zg/liter. Thus, for 8 months, the CyA dose was 1300 to 1500
mg/day. Serum creatinine remained under 200 moIes/liter. In the 8th
month he was investigated for malaise and fever and was found to have
developed both a tender splenomegaly and two monoclonal peaks in
serum gamma globulins, one IgGL, the other IgMK, indicating a
lymphoproliferative disorder. Both light chains were present in urine.
On stopping sulfinpyrazone, without an altered dose of CyA, CyA
blood levels immediately rose threefold (to over 300 zg/liter). Sub-
sequent CyA requirements fell to 300 mg/day. On this dose the
monoclonal peaks almost disappeared within 2 months and he felt very
well. The spleen became normal. CMV infection was not implicated.
Although the longterm outcome remains unknown, we conclude that
sulfinpyrazone interfered with CyA assays and lead to excessive CyA
dosage with induction of ?-malignant lymphoid clones. The rapid
disappearance of monoclonal protein and splenomegaly suggests that
CyA-induced lymphoproliferation may be reversible if the dose is
drastically reduced.
The prognostic value of renal allograft biopsy. P. S. Parfrey, Y. L.
Kuo, J. A. Hanley, J. Knaack, Z. Xue, R. Lisbona, and R. D.
Guttmann. Royal Victoria Hospital, McGill University, Montreal Can-
ada. We studied 120 patients to assess the prognostic use of renal
allograft biopsy in the first 3 months after transplantation. To determine
whether morphological data (in biopsies done where the diagnosis was
not clear or clinical rejection was deemed severe) improved the
prognostic usefulness of the clinical data at the time of biopsy, we
performed multiple logistic regression relating clinical and morphologi-
cal variables at the initial biopsy to the outcome (return to dialysis) I
year after the biopsy. Thirty-five patients returned to dialysis during the
first year after transplantation. A categorical variable which took into
account both the serum creatinine and its rate of change before biopsy
(creat) was the best clinical predictor of the return to dialysis. Further
increase in x2 occurred with the type of donor, number of transfusions,
and age. The best morphological predictor of outcome was interstitial
hemorrhage, followed by vascular endothelial proliferation, glomerular
endothelial swelling, and glomerular necrosis. Either clinical alone or
morphological variables were good predictors of good outcome but
poor predictors of the return to dialysis. Combining both sets of
variables the best predictor of the return to dialysis was interstitial
hemorrhage, followed by creat, glomerular endothelial swelling and
type of donor. Using all variables we produced an index, from 0 to 1, to
predict the outcome: 65 patients had an index greater than 0.8 of whom
63 (94%) did not return to dialysis, 18 had an index less than 0.2 of
whom 17 (94%) returned to dialysis. The remaining 27 patients had an
index less than 0.2 greater than 0.8 of whom 15 (56%) returned. We
conclude that a transplant biopsy does not improve the prediction of
good outcome derived from clinical data, but it greatly inproves the
prediction of return to dialysis.
Cyclosporin immunosuppression in cadaver kidney recipients with a
remote positive crossmatch to the current donor. P. Belitsky and The
Canadian Transplant Study Group. There is controversy about trans-
planting cadaver kidneys into recipients who have a remote serum with
a positive crossmatch against a current donor, even though the current
serum is negative. The Canadian Transplant Study Group established
an ancillary prospective trial to study the effectiveness in this situation
of initial immunosuppression with intravenous cyclosporin A (CYA)
and high dose steroids. Entry requirements included two blood trans-
fusions and the remote positive serum being from at least 3 months
earlier. Intravenous CYA was begun preoperatively at a dose of 3 to 4
mg/kg/day and switched subsequently to the oral route, titrating the
dose according to the CYA blood levels. Methylprednisolone was given
intravenous intra-operatively followed by prednisone, I mg/kg/day,
tapering to 0.2 mg/kg/day by day 60. Seventeen patients from three
centers were entered, ten first transplants and seven repeat transplants.
Of the ten first transplants, two were lost within 2 weeks, and one was
lost at 25 months; seven were still functioning, 6 to 26 months after
transplantation (mean followup, 18.4 months). Of the seven repeat
transplants, four failed within 8 weeks; another failed at 18 months, and
only two were still functioning, one each at 16 and 20 months. All seven
repeat patients had lost their first graft from rejection within 60 days of
transplantation. Results from this small series of patients suggest that a
remote positive crossmatch is an ominous prognostic factor in re-
transplants when the initial transplant was lost from rejection, even
with a current negative crossmatch and immunosuppression with intra-
venous CYA and high dose steroids. For the first grafts, however, the
remote positive crossmatch did not appear to affect the outcome of
transplantation adversely under this immunosuppression regimen.
A specific antibody to vasopressin (VP) in humans with high sensitivity
to measure VP in plasma. D. Bichet, C. Kortas, C. Manzini, and C.
Sauvé. Centre de Recherche et Service de Néphrologie, Hôpital du
Sacré-Coeur, Université de Montréal and Hôpiial Général, Université
d'Ottawa, Ottawa, Canada. A 26-year old patient with a diagnosis of
complete central diabetes insipidus since age 9, was initially treated
with pitressin tannate in oil (PTO). At age 13, a progressive therapeutic
resistance to the administration of PTO was noted as dosages were
increased to control the patient's polyuria. Minor allergic symptoms
occurred after each administration of PTO. Later on, the patient was
treated successfully with dDAVP (l-desamino-8-D arginine vasopres-
sin). Serial dilutions of the patient's plasma were incubated with
'251-arginine vasopressin ('251-AVP), free and bound fractions were
separated with dextran-charcoal. A 50% specific binding was obtained
for a final dilution of 1:625. 25I-AVP was readily displaced by cold AVP
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(nonspecific binding <2%). The patient's antiserum was sensitive
enough to develop a radioimmunoassay to measure AVP since 0.25
pg/tube could be detected with a 50% displacement for 5 pg/tube (logit
B/Bo = 0.79 — 66 log AVP, r =
—0.9989). Of interest, cross reactivity
studies showed that lysine-vasopressin (LVP) was better recognized
than AVP (B/Bo = 50% for 3 pg of LVP and 5 PG of AVP) and could
be attributed to large concentrations of LVP (pork vasopressin) in PTO.
Cross-reactivity was less than 5% for arginine-vasotocin, oxytocin, and
dDAVP. We have demonstrated a specific and sensitive antibody to VP
in humans associated with therapeutic resistance to PTO.
Role of vasopressin (AVP) in the abnormal water excretion in nephrotic
patients (NP). D. Bichet and C. Manzini. Centre de Recherche et
Service de Nephrologie. Hôpital Sacré-Coeur, Université Montréal,
Montréal, Canada. The mechanism of the abnormal water excretion in
NP remains unclear. Of 24 stable, consecutive, adult NP (urinary
protein excretion 10.4 1.5 g/24 hr; serum albumin 1.98 0.1 g/dl) who
received a 20 mI/kg waterload, 16 displayed abnormal water excretion
("non-excretors," group I) as they excreted 43 6% of the waterload
in 5 hrand had a minimal urinary osmolality (minUosm-mOsm/kg H20)
of 205 45. Eight patients (excretors, group 2) had normal water
excretion as they excreted 97 5% in 5 hr and had a minUosm of 62
4. Basal serum sodium and effective plasma osmolality were compa-
rable in groups 1 and 2, respectively, 139.8 1.2 vs. 140.1 0.6
mEq/liter and 273.3 1.5 vs. 274.6 1.1 mOsmlkg H20. A sensitive
radioimmunoas say (B/Bo = 50% for 1.2 pg/200 pl) was used to assess
the role of plasma AVP. Basal supine, basal upright, and mean AVP
values after the water load were significantly higher in group 1
respectively, 4.4 1, 9.3 2.9, 2.9 0.5 pg/mI, than in group 2: 1.4
0.3, 1.8 0.5, 1.2 0.1 pg/mI, all P <0.025. Group 1 patients also had
a lower glomerular filtration rate (72.6 71 vs. 105.6 5.3 rnllmin/l.73
m2, P <0.005) and a higher, although nonsignificant mean arterial blood
pressure (98.6 2.9 vs. 88.5 4.9, P = 0.1). A lower effective blood
volume (EBV) in group I was suggested by a lower fractional excretion
of sodium (0.41 0.1 vs. 0.77 0.1%, P < 0.05) and a higher plasma
renin activity (3.4 vs. 1.9 ng/ml/hr P < 0.025) and plasma aldosterone(15.5 vs. 8.8 ng/dl, P < 0.005). We conclude that both nonosmotic
stimulation of AVP, possibly secondary to a decrease in EBV, and
intrarenal factors, contribute to the abnormal water excretion in ne-
phrotic patients.
Contribution of altered ADH release to the renal concentrating defect in
chronic metabolic alkalosis. L. N. Peterson, D. Sztorc, J. Kucharczyk,
and D. Z. Levine. Departments of Pediatrics, Physiology, and Medi-
cine, University of Ottawa, Ontario, Canada. To determine how
chloride-depletion may alter renal concentrating ability, we developed a
chronic model of metabolic alkalosis in rats fed a chloride-free diet and
subjected to drainage of gastric acid through indwelling fistulae.
Alkalotic animals displayed persistent hyponatremia, reduced plasma
osmolality (Posm), polydipsia (two times control), and a renal concen-
trating defect. When animals were pair-watered to prevent polydipsia,
Posm did not increase and urine concentrating ability was not improved.
Despite the presence of reduced Po,m (281 4.0 vs. 304 1.7, P <
0.001) in evolemic alkalotic rats, ADH measured by radioirnmunoassay
revealed normal hormone levels. However, when ADH was adminis-
tered to pair-watered dehydrated alkalotic rats (500 mU b.i.d.) there
was a significant increase in maximal urine osmolality although, not to
the same values measured in sham-operated control rats (*P < 0.05).
Maximum U0,, (mosrn/kg H20)
Sham rats Alkalotic rats
Ad-lib H2O intake 2754 145.1 P < 0.001 1853 107.8
Pair-watered
Pair-watered + ADH
2851 130.0
2615 75.6
P < 0.001
P < 0.05
1967 131.71w
2342 57.8-'
These results indicate that the concentrating defect in chronic metabolic
alkalosis can be attributed to both a primary derangement in the renal
concentrating process and an impairment in ADH release, but not
to polydipsia. Further, the data support the view that the osmotic
threshold for ADH release is reset to a lower Po,m in metabolic
alkalosis, however, maximum ADH levels do not appear to occur
during dehydration.
Effect of 1,25(OH)2D3 on renal compensatory hypertropby. J. Jobin
and L. R. Dufresne. Centre de Recherches Cliniques, Hopital Saint-
Luc, Montréal, Québec, Canada. Previous studies in rats have shown
that a low calcium diet and parathyroid hormone administration en-
hance the renal compensatory hypertrophy (RCH) that occurs following
contralateral nephrectomy (UNI-NX). Since both maneuvers increase
circulating 1 ,25(OH)2D3, we have examined the influence of this hor-
mone on RCH. Experiments were performed on vitamin D deficient
male Wistar rats pair fed a diet containing 1.0% calcium and 0.8%
phosphorus. Following excision of the right kidney, daily doses of 0, 5,
10, 20, 40, and 80 pmoles of l,25(OH)2D3 were infused. RCH was
assessed on the left kidney 3 days after surgery, The weight gain of the
remaining kidney was proportional to the dose of 1 ,25(OH)2D3 admin-
istered:88 17, 129 14, 164 6,191 7,202 ll,and229 14
mg. Parallel increases in total RNA content of the kidney were
observed: 1.07 0.11, 1.25 0.03, 1.63 0.22, 1.82 0.11, 1.74
0.11, 2.07 0.06 mg and proportional changes in 3H thymidine
incorporation into acid insoluble material were noted. Mean plasma
calcium were: 6.2 0.2, 8.4 0.5, 10.2 0.3, 11.0 0.4, 11.7 0.2,
and 12.9 0.8 mg% for each group. No differences in plasma
phosphate were noted. In animals receiving 10 pmoles of 1 ,25(OH)2D3
or more, the degree of RCH surpasses the one observed in control
nonvitamin D-depleted animals (kidney weight gain after contralateral
UNI-NX: 156 8 mg). These studies indicate that 1 ,25(OH)2D3 is a
strong stimulator of RCH and might well mediate the enhancing effect
observed with parathyroid hormone or a LCaD.
Impact of infra-aortic clamping on renal function in patients volume-
expanded with saline (S) and mannitol (M) and dopamine. M. Paul, R.
Byrick, and M. Goldstein. University of Toronto, Toronto, Ontario,
Canada. Renal function and hemodynamics were evaluated in a pro-
spective randomized study of 18 patients undergoing elective infra-renal
aortic cross clamping. All patients were ECFV-expanded with S and in
addition half received M (125 g bolus and 200 mg/kg/hr) and D (3
g/kg/min) 20 mm prior to and throughout the clamped period. Signifi-
cant declines in GFR occurred post induction (Ind) and postaortic
clamp release, despite stable hemodynamics and FENa. There were
significant elevations in plasma renin activity (PRA) corresponding to
the falls in GFR. All renal function parameters returned to pre-
induction values I day postoperative.
Pre-ind
S MD
—_Pre-clamp
S MD
Aortic ci
S
amp
MD
GFR 96 93 62 91 68 72
FENa 1.9 1.9 2.3 4.9 3.2 7.8
CI 3.5 3.2 2.9 3.8 2.4 3.0
MAP 107 99 102 93 93 92
PCWP 14 17 15 15 14 12
PRA 0.15 0.30 0.20
Post-clamp
S MD
1—4 Hr
S MD
GFR 56 47 64 67
FENa 3.4 4.4 3.0 4.4
CI 3.2 2.6 2.9 3.0
MAP 95 81 106 104
PCWP 16 14 12 12
PRA 0.33
In conclusion, the nadir in GFR occurred following aortic clamp release
and was associated with a significant rise in PRA, independent of any
hernodynamic change. Therefore the renin-angiotensin system may be
important in the genesis of renal functional change. There was no
benefit demonstrated of the addition of M and D to the volume
expansion by saline.
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Osteoclast activity in endstage renal disease (ESRD). M. Kaye. Divi-
sion of Nephrology, Montreal General Hospital, Montreal, Ontario,
Canada. We have previously shown that osteoclasts are larger in
patients with ESRD. The present study was designed to evaluate their
functional activity by relating the osteoclast size to the corresponding
size of the Howship lacuna. Iliac crest biopsy specimens from 28
patients and 11 control subjects were studied. The bone was embedded
in glycol methacrylate at 4°C and 125 to 250 2-itm serial sections cut.
They were stained for acid phosphatase and counterstained with
hematoxylin. Multinucleated acid phosphatase positive cells contiguous
with the trabecular surface were studied by finding the section contain-
ing the midpoint of the cell and measuring the osteoclast area and the
adjacent lacunar area. Twenty-one percent of the control cells and 16%
of the ESRD cells had no lacunae. Using all pairs of observations the
correlation between osteoclast and lacunar area was 0.62, P < 0.001
and for the controls only was 0.87, P < 0.001. These findings indicate
that larger cells remove more bone, that is, they are functionally more
active. Because osteoclasts in ESRD are larger than normal supports
the view that each ESRD cell produces more resorption than a control
cell.
The urine anion gap (A/G): Critical clue to resolve a diagnostic
dilemma. M. L. Halperin, J. Hilton, R. Josse, and A. Vandenbroucke.
St. Michael's Hospital, Toronto, Canada. Usually, ketoacidosis (KA)
presents few if any diagnostic or therapeutic problems; we shall report
a patient in which KA was clinically occult and biochemically obscure.
The cardinal features included mild ethanol intake, acute pancreatitis,
metabolic acidosis (pH 7.29, HCO3 10 mM) with a normal A/G of 12
mEq/liter (HCMA), severe hyperlipidemia (TG 50 mM), modest
hyperglycemia (11 mM), and a 2+ but not 4+ serum ketone. No cause
for the HCMA was identified (HCI intake, GI, or urine bicarbonate
loss). Furthermore, plasma albumin was normal; dysproteinemias and
abnormal halides were absent. Nevertheless, KA was suspected clini-
cally. In addition, the urine A/G was 103 mEq/liter in the absence of
renal disease (that is, the expected large quantity of urine NH4+ must be
masked by an unmeasured anion, that is, /3-hydroxybutyrate (/3HB);
confirmed by subsequent analyses). Despite the initial normal plasma
A/G, the blood /3HB was 8 mM; after 24 to 36 hr of the usual treatment
for KA, the bicarbonate (25 mM) and A/U (12 mEq/liter) were normal.
This apparent paradox regarding the A/G and I3HB was due to a falsely
high value for chloride caused by the turbidity of the hyperlipemic
serum. When re-estimated by ion selective electrodes, the chloride was
102 and not 112 m. Finally, the small alcohol ingestion could explain
in part the modest hyperglycemia and the absence of a 4+ test for serum
ketones. in conclusion, KA was initially obscured by factors influ-
encing the plasma A/U and the test for ketones. The urine A/G can be
helpful in the diagnosis of HCMA.
Dialyzer performance over prolonged re-use R. F. Gagnon, M. Kaye,
B. Muihearn, and D. Spergel. Division of Nephrology, Montreal
General Hospital, McGill University, Montreal, Ontario, Canada. The
performance of hollow fibre dialyzers (Gambro 1 20M) undergoing
automated reprocessing (Lixivitron II, Harco Medical, USA) was
evaluated over prolonged re-use. Clearances were measured in viva
after 1 hr of dialysis using QB200, QDSOO, and a negative pressure of 0
mm/Hg. Clearances were repeated in vitro after cleaning, together with
vitamin B12 clearance. In a separate study neutrophil counts were
measured at 0, 15, 60, and 120 mm after the beginning of dialysis.
Neutrophils (% of control) and clearances (mI/mm) +
Number of uses 1 10 20 30
Number of patients 10 10 7 6
Urea 170±3 167± 2 165±1 162± 6
Creatinine 144 1 152 2 145 5 143 5
Phosphate 132 2 136 2 127 3 116 8
B12 (in vitro) 25 3 25 3 — 30 2
Neutrophils at 15 mm 7 2 6 3 6 2 —
(+ Mean SEM)
No significant differences were found with re-use and the in vitro data
were similar. Neutropenia was present throughout at the 4.3%
hypochlorite concentration recommended with the Lixivitron. It was
concluded that with this equipment dialyzer function is maintained for
at least 30 uses and the cleansing process removed the (7 protein)
coating which would otherwise prevent neutropenia.
Aluminum does not impair vitamin D3 metabolism in D-deficient rats.
A. Hodstnan and G. Jones. University of Western Ontario, London,
Ontario, and Queen's University, Kingston, Ontario, Canada. Chronic
parenteral nutrition may lead to bone aluminum (Al) accumulation,
osteomalacia, and low serum levels of 1,25(OH)2 vitamin D3, while
Al-associated osteomalacia in dialysis patients is resistant to vitamin D
therapy. To determine whether Al affects D3 metabolism in viva.
weanling rats were raised on D-deficient (D—) diets, and half received
parenteral Al, cumulative dose 15 mg i.p. over 4 weeks (Al+); there-
after all rats were given 5 g 3H-D3 s.c. (1 z Ci/zg). Serum(Se)
calcium(Ca), phosphate(Pi) and 3H-D3 metabolites were followed over
time.
Time (hr) 0 8
-
SeCa
mg/dl
l,25D3
pg/mi
24,25D3
ng/ml
AI+
Al—
Al+
Al—
Al+
Al—
3.5 0.2
2.9 0.2
6.8 6a
4.0 0.2
234 62
266 77
Time (hr) 24 72 96
SeCa
mg/dl
1,25D3
pg/mI
24,25D3
ng/ml
7.5
5.4
801
815
0.15
0.09
2a
0.2
120
76
0.03
0.02
9.7 0.2'
8.5 0.1
228 12°
699 56
0.54 0.2
0.22 0.1
7.9 0.3
8.1 0.3
157 39
275 103
1.1 0.2°
0.49 0.1
Data are mean SE, N = 4, a = P < 0.05 Al+ vs. Al—. No consistent
differences in SePi or 2SOHD were seen. However, (1) SeCa rose faster
in A1+ vs. Al— rats, but this was independent of 1,25 levels which
increased in parallel between groups over the first 48 hr. (2) The
switch-over between I ,25D and 24,25D formation occurred 24 hr earlier
in Al+ rats, perhaps in response to the earlier rise in SeCa. Thus, Al
loading does not inhibit D— metabolism in this animal model.
Successful treatment of renal vein thrombosis with streptokinase. P. E.
Barré, J. Boshinsky, D. R. Roy, A. Roy, and B. Cooper. Division of
Nephrology, Radiology and Hematology, Royal Victoria Hospital,
Montreal, Canada. Sudden complete obstruction of the renal vein due
to thrombosis is an infrequent event in a non-nephrotic adult.
Streptokinase has been successfully used to treat acute thrombosis of
the coronary vessels but results in renal vein thrombosis are limited and
controversial. A 25-year-old insulin-dependent female diabetic patient
was admitted to the hospital with a 5-day history of severe right flank
pain accompanied by nausea, vomiting, and fever of 38°C. Her past
history included recurrent skin infections and asymptomatic bacteri-
uria. She had early diabetic retinopathy and mild proteinuria. She had
been taking estrogen containing contraceptives for 5 years. An IVP of
I day PTA revealed a nonfunctioning enlarged right kidney. On
admission BP 130/80 and T 37.5°C. There was marked tenderness and
fullness in the right flank. Laboratory data revealed a creatinine 1.3
mg/dl, BUN 19 mgldl, SGOT 31, LDH 204, and alkaline phosphatase
672 lU/liter. Hemoglobin 11.5 g/dl, WBC 17,700 mm3, and platelets
255,000. Urinalysis revealed 1+ protein, 4+ glucose, and trace ketones
with 50 to 100 WBCs, 5 to 10 RBC's, and bacteria on unspun sediment.
Renal ultrasound confirmed thrombosis of right renal vein without
extension to the IVC and a patent left renal vein. The patient was
started on streptokinase with 250,000 IU initially and 100,000 IU hourly
for 12 hr via a peripheral vein followed by heparinization. A repeat
ultrasound confirmed disappearance of the thronibus. Creatinine was
0.8 mg/dl and a second renal scan confirmed renewed function of the
right kidney. This case demonstrates that streptokinase administered
600 Abstracts
peripherally is effective for treatment of acute renal vein thrombosis
and that renal ultrasound may be the examination of choice in making
the diagnosis.
Longterm followup of patients having undergone unilateral nephrec-
tomy during childhood. P. Robitaille, J.-G. Mongeau, L. Lortie, and P.
Sinnassamy. Department of Pediatrics, Nephrology Division, Hópital
Ste-Justine, Université de Montréal, Montreal, Canada. In 1982, it was
reported that rats with unilateral nephrectomy showed a progressive
decline in GFR when placed on a high protein diet. It was also reported
that increased proteinuria and hypertension were found in longterm
kidney transplant donors. It was proposed that hyperperfusion of the
reduced renal mass could lead to proteinuria, hypertension, and kidney
failure after several years. To test this hypothesis, we assessed renal
function in 27 patients who had complete unilateral nephrectomy during
childhood. The average age at the time of nephrectomy was 2.1 years (I
month to 12 years). Indications for nephrectomy were severe hydro-
nephrosis in 18 patients, Wilms' tumor in 4, renal dysplasia in 3, and
trauma in 2. Mean followup time post nephrectomy was 23.3 years (17
to 33 years). Creatinine clearances averaged 83.9 18.3 mI/min/m2 (SD)
for the entire group. Only three patients had clearances below — 1 SD
with values of 59, 59, and 62 mi/minIm2, respectively. Twenty-four hour
proteinuria was negative (that is, < 100 mg) in 24 patients and between
100 to 300 mg in three patients. The mean systolic and diastolic blood
pressures I SD were of 116 13,3 and 78.3 6.4 mm Hg,
respectively. Only three patients had blood pressure readings slightly
above normal: Two had a systolic of 140 mm Hg and one a diastolic of
90 mm Hg. Thus, evidence of kidney damage more than 20 years after
nephrectomy could not be documented in this study. It would appear
that, at least when renal mass loss occurs during childhood, nephron
hyperperfusion has no deleterious effects of clinical significance on the
kidney.
Pre-natal diagnosis of kidney disorders by ultrasound. B. 7'. Steele, J.
DeMaria, and A. Toi. Departments of Pediatrics, Surgery and Radiol-
ogy, McMaster University Medical Centre, Hamilton, Ontario, Can-
ada. The investigation of 29 infants, in whom an abnormality of the
urinary tract was found pre-natally, showed the following disorders in
27 patients (25 males and 2 females).
Multicystic kidney 8 Uretero-vesical junction
Uretero-pelvic junction obstruction 1
obstruction (UPJ) 7 Pelvic teratomaIobstruction 1
Prune belly syndrome 4 Vesico-ureteric reflux 1
Posterior urethral valves 2 Urethral atresia 2
Polycystic kidneys "adult"
Pre-natal ultrasound had been done for a variety of reasons between 17
and 36 weeks gestation. In addition to two false positives, three cases
were missed—two with infantile and one with adult polycystic kidney
disease. Pre-natal surgery was performed on one fetus and four preg-
nancies were terminated. Five of seven infants with UPJ obstruction
had successful surgery in the first 3 months of life. One of the two
infants who did not have surgery spontaneously improved over 1 year
and the other has a non-functioning kidney with a thin rim of cortex
only. Six of the seven infants with UPJ obstruction had no clinical signs
of disease prior to Surgery. A diuretic isotope renal scan was the most
useful investigation, both in assessing the degree of obstruction and in
distinguishing obstruction from a multicystic kidney. A specialized
team approach is recommended both for counseling parents and for the
subsequent investigation and management of these infants.
Results of a controlled trial of alternate day prednisone (ADS) in
idiopathic membranous glomerulonephritis (IMGN). D. Catiran, C.
Cardella, R. Charron, J. Roscoe, E. Cole, R. Bear, and P. Corey.
University of Toronto Glomerulonephritis Group, Toronto, Ontario,
Canada. The trial has entered 171 IMGN patients (P) to assess the
effects on renal function of 45 mg/m2 of ADS(D) given for 6 months
versus no specific treatment (C). P were stratified by pathology into
stages 1,2(A) or 3,4(B). Secondary causes were ruled out. Six D
withdrew due to side effects. Below results are on 86 P followed 2 years.
ESRD developed in 14 P (7C,7D) plus five non-renal deaths (lC,4D) oc-
Parameters Treatment (D) Control (C)
Stage/P A/l9 B120 A129 B/18
Mean age 38 47 40 39
Initial(I) CrCl, mI/mm 87 62 96 92
I proteinuria, g/day 5.3 9.2 5.0 4.9
Follow-up, months 44 48 40 38
Mean change CrCI at
1) 18 months --0.3 1.3 —0.3 —4.0
2) 24 months —0.5 1.2 —2.4 —3.4
3) 36 months 0.13 0.5 —3.0 0
Final vs. initial proteinuria (%)
Normalized
<50%
Initial
No
response
(Stage) A B A B A B
Treatment 32 24 34 32 34 44
Control 34 18 24 29 41 54
curred. Non-parametric analysis on CrCI and I/Cr at 36 months. D vs. C stage
A P < 0.03, but stage B P = NS. P = NS regarding proteinuna. ADS
statistically preserves GFR longterm, but clinical relevance is questionable.
Colchicine reduces proteinuria in passive Heymann nephritis (PHN). L.
S. Mimer, D. Lotan, P. R. Goodyer, J. S. C. Fong, and B. S. Kaplan.
Department of Nephrology, McGill University, The Montreal
Children's Hospital Research Institute, Montreal, Quebec, Canada.
We decided to study the effect of coichicine on protein excretion in
PHN because beneficial effects have been shown with its use in
nephrotoxic serum nephritis in rats. Adult rats (150 g) were treated with
colchicine (0.06 mg i.p.) each day for 2 weeks following injection of
PHN antiserum; controls received saline. Coichicine significantly re-
duced proteinuria (73 14 vs. 249 86 mg/24 hr, P < 0.05) and
albuminuria (36 8 vs. 130 43 mg/24 hr, P < 0.05) after 14 days of
treatment. Serum cholesterol was significantly reduced in treated (69
52 mg/dl) compared with control rats (132 41 mg/dl, P < 0.05).
Simultaneous administration of indomethacin (0.7 to 1.3 g/g/day)
prevented a significant reduction in the proteinuria in the treated
animals compared to controls (144 44 vs. 249 85 mg/24 hr, P >
0.05). A similar effect was seen on albuminuria (108 36 vs. 130 43
mg/24 hr, P> 0.05). In a repeat study, rats were treated with 0.05 mg
daily for 14 days followed by 0.025 mg daily for a further 14 days.
Proteinuria was significantly reduced at 14 days (94 49 vs. 239 45
mg/24 hr, P < 0.05). Creatinine clearance was similar in coichicine-
treated animals after 28 days (1.66 0.33 vs. 1.19 0.078 mI/mm, P>
0.05). These studies indicate that colchicine reduces proteinuria,
albuminuria, and hypercholesterolemia in rats with PHN. This reduc-
tion in proteinuria does not seem to be the result of a decline in GFR.
The beneficial effect of colchicine may depend on the integrity of
endogenous prostaglandin synthesis since it is blunted by indometh-
acm.
The psychosocial outcome of patients with ESRD assigned to the
cadaveric transplant (CT) waiting list: A prospective study. G. Rodin, K.
Voshart, D. Cattran, S. Fenton, P. Halloran, and C. Cardella. Toronto
General Hospital, Toronto Western Hospital, Toronto, On1rio, Can-
ada. Although renal transplantation has been described as superior to
dialysis as a treatment for ESRD, studies comparing quality of life are
either poorly controlled or do not include transplant failures. We have
conducted a prospective study of all patients placed on a waiting list for
CT to determine whether this treatment offers an improvement in the
quality of life. Measures used include the Sickness Impact Profile (SIP)
to assess illness-related dysfunction in psychosocial and physical areas.
Patients were assessed when placed on the waiting list and again 6
months after CT (N = 34) or 6 months after remaining on the waiting
list without a transplant (N = 23). Age, mortality, and duration of
dialysis in both groups did not differ. There were 6 of 34 (18%) graft
failures. Patients with successful CT showed an overall improvement of
51% (P< 0.001) on the SIP with improvement of over 50% in emotional
behavior (P< 0.000) and social interactions (P < 0.01) ambulation (P<
0.0005), hygiene and transfer (P < 0.04), sleep and rest (P < 0.01),
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dietary behavior (P < 0.0005), home management (P < 0.05) and
recreation and hobbies (P < 0.0007). By contrast there was no sig-
nificant change in patients who remained on the waiting list for a CT or
who received a graft which failed. We have quantified the marked
improvement in psychosocial and physical functioning with successful
CT in contrast to the lack of change in patients who remain on the
waiting list. More surprising is that morbidity was not increased with
graft failures. This study thus provides objective support for cadaveric
transplantation as the quality treatment for ESRD.
Physical fitness (PF) and the metabolic profile (MP) of two selected
groups of dialysis patients. D. C. Cattran, F. Thome, S. S. A. Fenton,
W. Geisler, G. Steiner, J. Harrison, and 0. Javit. Department of
Medicine, University of Toronto, Toronto, Ontario, Canada. We com-
pared 31 patients' PF and MP prior to starting an exercise program.
Age, smoking, and alcohol history were similar in the 17 hemodialysis
(HD) and 14 continuous ambulatory peritoneal dialysis (CAPD) pa-
tients. Differences were sex ratio: HD (M/F 15/2), CAPD (M/F 4/10) and
treatment duration HD (70 50 months) vs. CAPD (21 15 months).
Nutritional intake, total body nitrogen, and potassium and
anthropometric measurements were similar in the HD and CAPD
group. Biochemical parameters were similar aside from a higher hemo-
globin in the CAPD patients but red cell mass in mi/kg was equal.
Predicted maximum oxygen consumption stratified for age and sex was
equal in the two groups and was 55% of normal with fully 80% of the
patients in the very unfit to poor category. RBC mass and Vo2max
correlated closely (r = 0.76). The lipid profile in the standard CAPD
condition with dianeal in was markedly different from both dianeal Out
and the HD population. Cholesterol (CH) and triglycerides (TG) were
50% higher and had a strong positive correlation with a high fasting (221
pmoles/liter) and 2-hr p.c. (330 pmoles/liter) insulin values (despite
normal blood sugars). The total apo-B fraction was 90% higher than
normal in CAPD and increased with time on CAPD but was normal and
did not change on HD. Poor PF is seen in both HD and CAPD. The lipid
profile in CAPD has more atherogenic potential than HD and may
worsen with time on treatment. A regular exercise program may benefit
both the PF and MP of both groups.
An animal model of hemodialysis-induced polycystic kidney disease
(PKD). J. F. S. Crocker and S. H. Safe. Department of Pediatrics,
Daihousie University, Halifax, Nova Scotia and Department of Veteri-
nary Pharmacology, Texas A&M University, College Station, Texas,
USA. The development of PKD in approximately 40% of renal failure
patients on Iongterm hemodialysis (HD) has been reported. Others
noted that patients on HD accumulate the plasticizer di-2-
ethylhexylphthalate (DEHP) in blood and tissues. Prolonged exposure
to diphenylamine used in the manufacture of plastics induced PKD in
adult rats. We speculated that plasticizers leached from dialysis equip-
ment may induce PKD. Young Sprague-Dawley rats were divided into
three groups and fed chemicals three times a week for 1 year. Controls
(C) received the vehicle only. Second and 3rd groups received a
toluene-extracted leachate of dialysis tubing (LEACH) and DEHP
respectively at 2.1 mg/kg/feeding. Dosages were calculated to ap-
proximate human dialysis exposure on a body weight basis. Every 3
months randomly selected rats from each group were selected for renal
function studies and histologic examination. The 1-year group showed:
Group (N)
Tubular ectasia
NormalCortical Medullary Cysts
LEACH (36) 47% 11% 11% 28%
DEHP (21) 57% 0% 14% 24%
C (29) 41% 0% 7% 52%
This preliminary work suggests that longterm exposure to HD plasticiz-
ers may induce changes of PKD. Chi-square analysis of these data and
those from the shorter termed studies reveal a significantly different
distribution of structural abnormalities in the chemically treated group
compared to controls (P = 0.04).
Prognostic and diagnostic significance of transmission electron micros-
copy of urinary sediment in acute renal failure. A. H. Sklar, A. K.
Mandal, and J. B. Hudson. Department of Medicine, Medical College
of Georgia and Veterans Administration Medical Center, Augusta,
Georgia, USA. Conventional noninvasive methods to assess the etiol-
ogy and severity of acute renal failure (ARF) are not definitive. To
determine whether ultrastructural analysis of epithelial cells found in
the urinary sediment (US) of patients with ARF can be of help in these
regards, we studied US of 24 such patients by transmission electron
microscopy (TEM). The US was fixed in glutaraldehyde-formalin and
then prepared in the standard manner for TEM analysis which was
carried out within 24 hr. Pellets formed in all but two patients.
Evaluation of US revealed three patterns: type I-severely necrotic renal
tubular epithelial cells (RTEC); type Il-mild or moderate degeneration
of RTEC with signs of regeneration; type Ill-absence of RTEC. At 3
months of followup, none of six patients exhibiting type I changes
recovered any renal function. In contrast, eight of ten patients display-
ing type II changes recovered a substantial portion or all of their
baseline renal function as did all six patients with type III US (P <
0.005). Additional findings of diagnostic worth included the following:
the presence of platelet aggregates and fibrin in a patient with dis-
seminated intravascular coagulation; myeloid bodies in RTEC in a
patient with gentamicin toxicity; and urate crystals in papillary inter-
stitial cells in a patient with rhabdomyolysis. In conclusion, (1) TEM of
US is a noninvasive and relatively rapid method for the morphologic
evaluation of ARF, (2) TEM of US provides prognostic information and
may assist in determining the etiologic factor(s) in patients with ARF.
Causes and prognosis of necrotizing glomerulonephritis. P. 5. Parfrey,
T. A. Hutchinson, S. Jothy, B. C. Cramer, J. Martin, J. A. Hanley, and
J. F. Seely. McGill University, Royal Victoria Hospital, Montreal
Canada. Necrotizing glomerulonephritis (NGN) represents small vessel
vasculitis in the kidney. To assess its causes and prognosis we studied
all 32 patients who had this histological finding on kidney biopsy from
1969 to 1982 and compared them to those patients who had crescentic,
diffuse, or focal and segmental glomerulonephritis without necrosis (N
= 29). The diseases associated with NGN were systemic lupus
erythematosus (N = 6/15), Henoch-Schönlein purpura (N = 3/4),
Goodpasture syndrome (N = 4/7), Wegener granulomatosis (N = 6/6),
polyarteritis (N = 4/5), infective endocarditis (N = 2/3), and idiopathic
rapidly progressive glomerulonephritis (N 7/21). Comparison of
patients with and without NGN revealed no difference in outcome
(death or dialysis) 1 year after biopsy (38% vs. 43%) or in serum
creatinine 1 year later (4.6 vs. 4.8 mg/dl). The prognostic effect of NGN
was not obscured by unequal distribution of other adverse prognostic
factors in the two groups. The most important prognostic characteris-
tics we identified for outcome were serum creatinine at biopsy (x2
24.0, P < 0.0001) and the sum of activity and chronicity indices (x2 =
12.7, P = 0.0004). These were similarly distributed in patients with and
without necrosis; mean creatinine at biopsy was 4.3 vs. 4.2 mg/dl and
the sum of indices 7.8 vs. 8.0. Other factors such as clinical diagnosis
were not important prognostically and therefore could not explain our
results. We conclude that NGN in patients with active proliferative
glomerulonephritis has multiple causes. When renal function and histol-
ogy are controlled, the appearance of necrosis does not appear to have
prognostic significance.
The effect of peritoneal dialysis solution on viability of mouse resident
peritoneal cells. B. Gallimore, R. F. Gagnon, and M. M. Stevenson.
Montreal General Hospital Research Institute, McGill University,
Montreal, Canada. Viability of mouse resident peritoneal cells was
assessed following incubation with a commercial pentoneal dialysis
(PD) solution (4.25% dextrose). Groups of C57BL/6 mice included:
normal, sham-operated (right kidney electrocoagulated and the left
mobilized), and uremic (right kidney electrocoagulated and the left
removed). Animals were studied 6 weeks after the second surgery when
their blood urea nitrogen values were 26, 37, and 96 mg%, respectively.
Peritoneal cells were harvested by washing with cold phosphate-
buffered saline (PBS) or PD solution. Samples were centrifuged and
resuspended in their respective solution to standardize the cell count
and then incubated at 37°C. Cell viability, measured by trypan blue
exclusion, was recorded at 0 time, 20-mm and 60-mm incubation. No
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difference in percent viability was apparent within or between groups at
the two early test times. However, after a 1-hr incubation 83 8.6%
(mean SD) of PBS harvested cells remained viable in contrast to 47
7.1% viable cells harvested with PD solution. The magnitude of this
effect was similar in normal, sham-operated, and uremic animals. These
observations suggest that a considerable proportion of the peritoneal
resident cell population may be destroyed by short-term exposure to PD
solution.
Peritoneal sediment in continuous ambulatory peritoneal dialysis
(CAPD). C. Caron, L. Tetreault, G. Richard, M. Langlois, and A.
Poirier. University of Sherbrooke, School of Medicine, Sherbrooke,Quebec, Canada. The aim of our study was to assess the value of the
dialysate effluent sediment as a method of diagnosing peritonitis in
CAPD. Thirty-three samples of the peritoneal dialysate effluent of 14
patients without peritonitis (controls) and 20 samples of 8 patients with
peritonitis were examined in the following manner: After spinning for 10
mm at 4000 RPM they were placed on a clean slide. Cell counts were
done by two methods: (1) optic microscopy (40 x) and (2) by
hemocytometer (Coulter) and results were compared. A differential
count was done on 100 cells with a Wright stain on cytospin. The
peritoneal fluid of controls contained 1.6 0.6 white blood cells (wbcs)
and 5 1.5 red blood cells (rbcs) per high power field. On the first day
of peritonitis there were 570 274 wbcs and 15 6 rbcs. On cytospin
of controls there is a marked predominance (80%) of macrophages
whereas in peritonitis 70% of cells are polymorphonuclear leucocytes
and only 18% are macrophages, In peritonitis patients there was a good
correlation (r = 0.73, P < 0.001) between cell count under the high
power field and the Coulter count. The fluid becomes normal by day 6.
In conclusion, cellular populations of peritoneal fluid in patients on
CAPD are defined; its sediment analysis provides an important tool in
diagnosis and following peritonitis in these patients.
The renal uptake of glutamine during metabolic alkalosis. G. Lemieux,
E. Junco, C. Lemieux, R. Joffre, R. Perez, A. L. Kiss, and M. Rengel.
Renal Laboratory, Hótel-Dieu Hospital and Department of Medicine,
University of Montreal, Montreal, Quebec, Canada. Acute metabolic
alkalosis was induced in normal dogs by infusing sodium bicarbonate or
L-sOdiUm lactate during 60 mm to increase plasma bicarbonate from 20
to 30 mM. During the infusion of NaHCO3, the basolateral (no glutamine
in the urine) renal uptake of glutamine fell by 40% in contrast to a 45%
increase during the infusion of sodium lactate. Renal ammoniagenesis
fell during sodium bicarbonate loading but remained unchanged during
lactate infusion. During this maneuver, the renal extraction of lactate
rose considerably while the renal production of alanine increased
significantly. During chronic alkalosis induced by the administration of
electrolyte-free diet, sodium bicarbonate and diuretics during 7 to 9
days, plasma bicarbonate rose to 31 mat. In this group of dogs, the
basolateral renal extraction of glutamine fell by 40% and renal am-
moniagenesis by 35%. The present data demonstrate that the renal
uptake of glutamine is inhibited during acute and chronic metabolic
alkalosis induced by sodium bicarbonate. By contrast, the renal uptake
of glutamine is facilitated during the infusion of sodium lactate, The
data suggest that the augmented extraction of lactate by the kidney
facilitates the transport of glutamine at the basolateral site.
